skip to main content
Resource type Show Results with: Show Results with: Index

Reputation and power : organizational image and pharmaceutical regulation at the FDA

Carpenter, Daniel P., 1967-

Princeton : Princeton University Press c2010

Online access. The library also has physical copies.

  • Title:
    Reputation and power : organizational image and pharmaceutical regulation at the FDA
  • Author/Creator: Carpenter, Daniel P., 1967-
  • Publisher: Princeton : Princeton University Press
  • Creation Date: c2010
  • Language: English
  • Physical Description: xx, 802 p. : ill. ; 25 cm.
  • Bibliography: Includes bibliographical references (p. [753]-757) and index.
    Includes bibliographical references and index.
  • Subjects: United States. Food and Drug Administration; Pharmaceutical policy -- United States; Drugs -- Research -- United States
  • Notes: Includes bibliographical references (p. [753]-757) and index.
    Includes bibliographical references and index.
  • Contents: Introduction : The gatekeeper
    Reputation and regulatory power
    Reputation and gatekeeping authority : the federal Food, Drug, and Cosmetic Act of 1938 and its aftermath
    The ambiguous emergence of American pharmaceutical regulation, 1944-1961
    Reputation and power crystallized : thalidomide, Frances Kelsey, and phased experiment, 1961-1966
    Reputation and power institutionalized : scientific networks, congressional hearings, and judicial affirmations, 1963-1986
    Reputation and power contested : emboldened audiences in cancer and AIDS, 1977-1992
    Reputation and the organizational politics of new drug review
    The governance of research and development : gatekeeping power, conceptual guidance, and regulation by satellite
    The other side of the gate : reputation, power, and post-market regulation
    The détenté of firm and regulator
    American pharmaceutical regulations in international context : audiences, comparisons, and dependencies
    Conclusion : A reputation in brief.
    Introduction: The gatekeeper
    Conclusion: A reputation in brief.
    Cover; CONTENTS; LIST OF ILLUSTRATIONS; LIST OF TABLES; ACKNOWLEDGMENTS; LIST OF ABBREVIATIONS AND ACRONYMS; INTRODUCTION: The Gatekeeper; CHAPTER ONE: Reputation and Regulatory Power; PART ONE: ORGANIZATIONAL EMPOWERMENT AND CHALLENGE; CHAPTER TWO: Reputation and Gatekeeping Authority: The Federal Food, Drug and Cosmetic Act of 1938 and Its Aftermath; CHAPTER THREE: The Ambiguous Emergence of American Pharmaceutical Regulation, 1944-1961; CHAPTER FOUR: Reputation and Power Crystallized: Thalidomide, Frances Kelsey, and Phased Experiment, 1961-1966
    CHAPTER FIVE: Reputation and Power Institutionalized: Scientific Networks, Congressional Hearings, and Judicial Affirmation, 1963-1986CHAPTER SIX: Reputation and Power Contested: Emboldened Audiences in Cancer and AIDS, 1977-1992; PART TWO: PHARMACEUTICAL REGULATION AND ITS AUDIENCES; CHAPTER SEVEN: Reputation and the Organizational Politics of New Drug Review; CHAPTER EIGHT: The Governance of Research and Development: Gatekeeping Power, Conceptual Guidance, and Regulation by Satellite; CHAPTER NINE: The Other Side of the Gate: Reputation, Power, and Post-Market Regulation
    CHAPTER TEN: The Détente of Firm and RegulatorCHAPTER ELEVEN: American Pharmaceutical Regulation in International Context: Audiences, Comparisons, and Dependencies; CHAPTER TWELVE: Conclusion: A Reputation in Relief; PRIMARY SOURCES AND ARCHIVAL COLLECTIONS; INDEX
  • OCLC Number: 463970952
    655342133
  • Identifier: ISBN9780691141794;ISBN0691141797;ISBN9780691141800;ISBN0691141800;ISBN9781400835119;ISBN1400835119;LCCN2009044230